End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37,550 KRW | -1.83% | -0.13% | -17.47% |
Business Summary
Number of employees: 769
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sample Service Consignment
50.2
%
| 161,428 | 68.4 % | 94,194 | 50.2 % | -41.65% |
Anticancer Immunotherapy
18.6
%
| 30,671 | 13.0 % | 34,938 | 18.6 % | +13.91% |
Biologistics
13.8
%
| 19,237 | 8.1 % | 25,823 | 13.8 % | +34.23% |
Cell Therapy
7.4
%
| 6,584 | 2.8 % | 13,795 | 7.4 % | +109.52% |
Product
4.5
%
| 7,264 | 3.1 % | 8,397 | 4.5 % | +15.59% |
CDMO
3.0
%
| 7,685 | 3.3 % | 5,712 | 3.0 % | -25.67% |
Cell Storage
1.3
%
| 1,936 | 0.8 % | 2,509 | 1.3 % | +29.55% |
Others
1.2
%
| 1,314 | 0.6 % | 2,177 | 1.2 % | +65.70% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
88.1
%
| 219,412 | 92.9 % | 165,214 | 88.1 % | -24.70% |
United States
10.7
%
| 13,717 | 5.8 % | 20,125 | 10.7 % | +46.72% |
Japan
0.8
%
| 1,257 | 0.5 % | 1,538 | 0.8 % | +22.35% |
Others
0.4
%
| 1,734 | 0.7 % | 667 | 0.4 % | -61.55% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Park
CEO | Chief Executive Officer | 58 | 23-03-27 |
Jong-Seong Ahn
CTO | Chief Tech/Sci/R&D Officer | 59 | - |
Pil-Seok Seong
BRD | Director/Board Member | 58 | - |
Yu-Kyeong Hwang
BRD | Director/Board Member | 57 | 14-08-31 |
Seong-Il Hong
SAM | Sales & Marketing | 60 | - |
Nam-Chul Seo
AUD | Comptroller/Controller/Auditor | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yu-Kyeong Hwang
BRD | Director/Board Member | 57 | 14-08-31 |
Ho-Won Kim
BRD | Director/Board Member | 66 | 23-03-27 |
Dae-Hee Lee
BRD | Director/Board Member | 55 | 15-06-30 |
Pil-Seok Seong
BRD | Director/Board Member | 58 | - |
James Park
CEO | Chief Executive Officer | 58 | 23-03-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,800,344 | 8,276,818 ( 52.38 %) | 777,703 ( 4.922 %) | 52.38 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GC CELL CORPORATION 4.92% | 777,703 | 4.92% | 24,262,599 $ |
Company contact information
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.47% | 416M | |
-18.58% | 8.3B | |
+47.25% | 3.78B | |
-8.58% | 2.47B | |
-38.71% | 2.46B | |
-10.06% | 2.31B | |
-5.44% | 1.95B | |
-17.79% | 1.59B | |
-40.78% | 1.21B | |
+6.69% | 1.1B |
- Stock Market
- Equities
- A144510 Stock
- Company GC Cell Corporation